Bicocca Open Archive

Logo unimib boa
ROTA, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.409
AS - Asia 5.763
EU - Europa 5.085
SA - Sud America 878
AF - Africa 236
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 20
Totale 23.413
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.688
SG - Singapore 2.177
CN - Cina 1.400
IT - Italia 1.090
RU - Federazione Russa 741
DE - Germania 678
HK - Hong Kong 666
SE - Svezia 650
CA - Canada 649
BR - Brasile 641
VN - Vietnam 639
IE - Irlanda 474
UA - Ucraina 440
GB - Regno Unito 286
FR - Francia 220
IN - India 213
FI - Finlandia 140
ZA - Sudafrica 108
BD - Bangladesh 100
TR - Turchia 87
AR - Argentina 78
NL - Olanda 74
IQ - Iraq 64
AT - Austria 63
KR - Corea 63
DK - Danimarca 54
MX - Messico 48
JP - Giappone 47
PK - Pakistan 41
EC - Ecuador 40
CO - Colombia 36
ES - Italia 35
ID - Indonesia 34
PL - Polonia 33
SA - Arabia Saudita 30
MA - Marocco 27
VE - Venezuela 27
PH - Filippine 26
BE - Belgio 22
CL - Cile 21
EG - Egitto 18
IR - Iran 18
MY - Malesia 18
AE - Emirati Arabi Uniti 16
EU - Europa 16
KE - Kenya 15
ET - Etiopia 14
PY - Paraguay 14
TN - Tunisia 14
UZ - Uzbekistan 14
AU - Australia 13
DZ - Algeria 13
JO - Giordania 13
NP - Nepal 11
TH - Thailandia 11
AZ - Azerbaigian 10
CH - Svizzera 10
CZ - Repubblica Ceca 10
GR - Grecia 10
IL - Israele 10
PE - Perù 10
LB - Libano 9
RO - Romania 8
NO - Norvegia 7
CR - Costa Rica 6
JM - Giamaica 6
NZ - Nuova Zelanda 6
OM - Oman 6
PS - Palestinian Territory 6
TW - Taiwan 6
UY - Uruguay 6
BG - Bulgaria 5
BH - Bahrain 5
BO - Bolivia 5
MD - Moldavia 5
A1 - Anonimo 4
HU - Ungheria 4
KZ - Kazakistan 4
LT - Lituania 4
PT - Portogallo 4
RS - Serbia 4
SN - Senegal 4
ZM - Zambia 4
AO - Angola 3
KW - Kuwait 3
MN - Mongolia 3
MU - Mauritius 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BY - Bielorussia 2
GA - Gabon 2
GE - Georgia 2
HR - Croazia 2
KG - Kirghizistan 2
LV - Lettonia 2
NG - Nigeria 2
NI - Nicaragua 2
QA - Qatar 2
RE - Reunion 2
SI - Slovenia 2
Totale 23.385
Salva come PNG Salva come JPEG
Città #
Singapore 1.265
Woodbridge 978
Ann Arbor 953
Ashburn 930
Houston 721
Fairfield 661
Hong Kong 650
Chandler 605
San Jose 523
Toronto 467
Dublin 450
Jacksonville 450
Dearborn 369
New York 338
Frankfurt am Main 319
Wilmington 315
Milan 283
Seattle 271
Cambridge 258
Santa Clara 246
Beijing 214
Princeton 199
Dallas 168
The Dalles 154
Chicago 151
Hanoi 144
Ho Chi Minh City 138
Nanjing 138
Los Angeles 132
Shanghai 115
Council Bluffs 98
Altamura 95
Lauterbourg 90
Lawrence 82
Lachine 81
São Paulo 71
Moscow 67
Cape Town 60
Hefei 59
Nanchang 59
Buffalo 58
Guangzhou 57
Dong Ket 55
Vienna 55
Columbus 54
San Diego 50
Helsinki 48
Orem 48
Rome 48
Shenyang 46
Seoul 40
Andover 39
Hebei 37
Ottawa 37
Tianjin 34
Munich 33
Tokyo 31
Jinan 30
Jiaxing 28
Manchester 28
Boardman 27
Changsha 27
Warsaw 27
Baghdad 26
Boston 24
Da Nang 24
Hangzhou 24
Zhengzhou 24
Lissone 22
London 22
Mountain View 22
Fremont 21
Haiphong 21
Istanbul 20
Johannesburg 20
Montreal 20
Bologna 19
Brooklyn 19
Chennai 19
Phoenix 18
Dhaka 17
San Francisco 17
Mumbai 16
Nairobi 15
Rio de Janeiro 15
Salt Lake City 15
Brussels 14
Guayaquil 14
Huizen 14
Hải Dương 14
Ningbo 14
Norwalk 14
Nürnberg 14
Biên Hòa 13
Denver 13
Kunming 13
Lahore 13
Medellín 13
New Delhi 13
Pune 13
Totale 14.953
Salva come PNG Salva come JPEG
Nome #
Continuous monitoring of cerebral blood flow (CBF) and cerebral temperature in neurocritical care unit 461
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 383
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 351
Intracerebral hemorrhage in intensive care unit: early prognostication fallacies. A single center retrospective study 345
An Effective and Safe Strategy to Target Normothermia in Neurocritical Patients 333
Health related quality of life in chronic liver diseases 320
Trattamento con Sofosbuvir e Ribavirina nei pazienti hcv-positivi listati per il trapianto di fegato: un analisi di costo-efficacia 312
High-Resolution Intracranial Pressure Burden and Outcome in Subarachnoid Hemorrhage 310
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 309
Organ donation after brain death in refractory cardiac arrest treated with extracorporeal CPR 309
Alcohol consumption and site-specific cancer risk: A comprehensive dose-response meta-analysis 306
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 303
A noninvasive index of atrial remodeling in patients with paroxysmal and persistent atrial fibrillation: a pilot study 296
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 296
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 295
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 295
The impact of liver disease on the health-related quality of life 291
Intracranial pressure monitor insertion in traumatic brain injury: a single center, retrospective decision process analysis 285
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 283
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 282
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 282
Alcohol drinking and pancreatic cancer risk: a meta-analysis of the dose-risk relation 281
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 281
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 281
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 276
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 275
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 268
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 268
Random-effects meta-regression models for studying nonlinear dose-response relationship, with an application to alcohol and esophageal squamous cell carcinoma 267
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 267
Single-Incision Versus Standard Multiple-Incision Laparoscopic Cholecystectomy: A Meta-analysis of Experimental and Observational Studies 265
Alcohol drinking and risk of renal cell carcinoma: results of a meta-analysis 265
Health Related Quality of Life in the Major Liver Conditions 265
Difference in health related quality of life of chronic liver diseases and general population 256
Trajectories of early secondary insults after traumatic brain injury: a new approach to evaluate impact on outcome 256
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 255
External Ventricular and Lumbar Drain Device Infections in ICU Patients: A Prospective Multicenter Italian Study 254
Alcohol drinking and non-Hodgkin lymphoma risk: a systematic review and a meta-analysis 253
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 252
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 252
Incidence of pain after craniotomy in children 250
Organ donation in cardiac arrest patients treated with extracorporeal CPR: A single centre observational study 250
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 248
Alcohol drinking and laryngeal cancer: Overall and dose-risk relation - A systematic review and meta-analysis 246
Should new antiviral treatments be considered in elderly Chronic Hepatitis C patients? 246
A prospective evaluation of short-term and long-term results from colonic stenting for palliation or as a bridge to elective operation versus immediate surgery for large-bowel obstruction 244
Alcohol drinking and multiple myeloma risk - A systematic review and meta-analysis of the dose-risk relationship 244
Alcohol drinking and esophageal squamous cell carcinoma with focus on light-drinkers and never-smokers: A systematic review and meta-analysis 243
Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies 241
Alcohol drinking and epithelial ovarian cancer risk. A systematic review and meta-analysis 241
Alcohol consumption and lung cancer risk in never smokers: a meta-analysis 238
Should Sofosbuvir-Based All-Oral Treatment Be Considered In Elderly Chronic Hepatitis C Patients? 236
Meta-analysis on incidence of inhibitors in patients with haemophilia A treated with recombinant factor VIII products 235
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 234
A meta-analysis on alcohol drinking and gastric cancer risk 231
Light alcohol drinking and cancer: a meta-analysis 230
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 230
Trajectories of early secondary insults correlate to outcomes of traumatic brain injury: results from a large, single centre, observational study 230
A meta-analysis of alcohol drinking and oral and pharyngeal cancers. Part 1: Overall results and dose-risk relation 230
A meta-analysis on alcohol drinking and esophageal and gastric cardia adenocarcinoma risk 229
Factors influencing the decision to monitor intracranial pressure in traumatic brain injury. A large monocentric study 227
Strong excess risk of pancreatic cancer for low frequency and duration of cigarette smoking: A comprehensive review and meta-analysis 227
Incidence of inhibitors to recombinant factor VIII products – A meta-analysis of 1,852 previously untreated patients 226
A meta-analysis of alcohol drinking and oral and pharyngeal cancers. Part 2: Results by subsites 226
Alcohol drinking and cutaneous melanoma risk: A systematic review and dose-risk meta-analysis 224
The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation 223
Re: light drinking has positive public health consequences 219
Management of chronic hepatitis C (Chc) genotype 1 treatment-naïve patients in an era of rising opportunities and costs: A cost-effectiveness analysis 219
Donor safety in living donor liver donation: An Italian multicenter survey 219
Modelling body mass index and endometrial cancer risk in a pooled-analysis of three case-control studies 219
Is multifocality a prognostic factor in childhood hepatoblastoma? 217
Prospective multicentre cohort study evaluating the incidence of pain after craniotomy in children: first interim analysis. 217
Alcohol consumption and prostate cancer risk: A meta-analysis of the dose-risk relation 213
Management of Chronic hepatitis C (CHC) Genotype 1 treatment-naive patients in an era of rising opportunities and costs - A cost-effectiveness analysis of treatment options 209
Thromboembolic event rate in patients exposed to anti-inhibitor coagulant complex: a meta-analysis of 40-year published data 209
Cost-effectiveness of Sofosbuvir plus Ledipasvir Antiviral Treatment for Elderly Patients with Chronic Hepatitis C Genotype 1 207
A simulation study comparing performance of minimum P-value and Youden index as methods to find optimal cut-points of continuous variables 205
A meta-analysis of alcohol consumption and the risk of brain tumours 204
A meta-analysis on alcohol drinking and the risk of Hodgkin lymphoma 201
A random-effects meta-regression model for studying nonlinear dose-response relationship 199
Finding the optimal cut-point for Gaussian and Gamma distributed biomarkers 194
Incidence of Thrombo-Embolic Events in Relation to Activated Prothrombin Complex Concentrate Exposure: A Literature Meta-Analysis 185
Cut-pont finding methods for continuous biomarkers 182
Alcohol drinking and risk of leukemia-A systematic review and meta-analysis of the dose-risk relation 179
Optimal cut-point definition in biomarkers: The case of censored failure time outcome 176
Cut-Point Finding Methods For Continuous Biomarkers In The Presence Of Binary And Censored Failure Time Outcome 174
Sofosbuvir and ribavirinin in HCV-infected patients listed for liver transplantation: A cost-effectiveness analysis 173
Cost-effectiveness of new direct-acting antivirals to prevent post-liver transplant recurrent hepatitis 173
Is there a difference in inhibitor incidence with recombinant products? A meta-analysis of 2000 previously untreated patients 171
Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies 170
Dose-response relationship between cigarette smoking and site-specific cancer risk: Protocol for a systematic review with an original design combining umbrella and traditional reviews 167
Quantifying the Dose-Response Relationship Between Circulating Folate Concentrations and Colorectal Cancer in Cohort Studies: A Meta-Analysis Based on a Flexible Meta-Regression Model 164
Safety and Efficacy of Subcutaneous Hepatitis B Immunoprophylaxis using" on demand" Approach: A Single Center Experience 161
Safety and Efficacy of Subcutaneous Hepatitis B Immunoprophylaxis using “on demand” Approach: A Single Center Experience 160
Cut-point identification in biomarkers for a censored failure time outcome 160
Coffee consumption and risk of fractures: A systematic review and dose-response meta-analysis 157
Cut-point identification in biomarkers for a censored failure time outcome 151
Meta-Analysis on Incidence of Inhibitors in 1,945 Previously Untreated Patients Treated with Recombinant Factor VIII Products: Is There a Difference? 146
Does alcohol consumption increase the risk of cutaneous melanoma? Comments on a recent meta-analysis: reply from the authors 140
Totale 23.953
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.569
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.569
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021204 0 0 0 0 0 0 0 0 0 0 47 157
2021/2022954 40 79 109 98 33 90 29 78 50 84 71 193
2022/20232.189 232 687 171 198 134 338 18 144 178 7 64 18
2023/20241.591 52 69 52 89 174 520 273 75 94 18 16 159
2024/20253.163 227 363 185 127 286 134 164 134 372 448 226 497
2025/20267.562 803 358 586 703 1.009 443 1.078 417 703 787 675 0
Totale 23.953